Skip to main content
Sign In

Welcome to the website for the Department of Radiation Oncology at the University of Colorado Denver, affiliated with the University of Colorado Hospital.

Radiation Oncology Banner Image

Radiation Oncology

Quality, Performance, and Innovation in Cancer Care

Welcome to the Department of Radiation Oncology at the University of Colorado School of Medicine. Our mission is to provide the highest quality care to patients with all types of cancers and certain benign tumors. The department aims to achieve excellence in professionalism and performance of our services. We seek to create a climate that fosters innovation and allows patients access to the newest cutting edge treatments.

The Department of Radiation Oncology is integrated within the award-winning, nationally celebrated University of Colorado Hospital, within the larger University of Colorado Health system. The University of Colorado Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center.

 – Brian D. Kavanagh, MD, MPH, FASTRO​, Professor and Interim Chair ​​​​​


In The News...

2/5/16 - Amini reports survival benefit with combination of external beam radiation therapy and seed implant for intermediate risk prostate cancer​
Dr. Arya AminiFourth-year resident Dr. Arya Amini recently published data on prostate cancer that has received national press attention. Dr. Amini and colleagues in the radiation oncology department, including senior author Dr. David Raben, analyzed the National Cancer Database and found combination external beam radiation therapy (EBRT) and brachytherapy provides a modest s​urvival benefit compared with brachytherapy alone for patients with intermediate-risk prostate cancer. 

Combination radiation therapy with EBRT and brachytherapy for intermediate-risk prostate cancer patients is currently being evaluated in the Radiation Therapy Oncology Group (RTOG) 0232 study. Continue Reading...​

1/6/16 - Vinogradskiy Receives Funding for Lung Cancer Trial
Dr. Yevgeniy (Jenia) Vinogradskiy, PhD, Assistant Professor of Radiation Oncology, has been recently awarded an R01 grant from the National Institute of Health to support a project entitled, “Clinical trial personalizing radiation therapy through a novel lung function imaging modality”.
Dr. Vinogradskiy received his PhD in Medical Physics from the UT MD Anderson Cancer Center before joining the University of Colorado faculty. The current project represents an evolution of his doctoral and faculty research work, which has involved the study of 4-dimensonal CT imaging as a tool to characterize lung function and facilitate planning for radiotherapy in the treatment of lung cancer. Continue Reading...​
9/1/15 - Dr. Karyn Goodman joins UCH Radiation Oncology
Unknown.jpegKaryn Goodman joins us on September 1st, 2015, as a Professor in the Department of Radiation Oncology.  Dr. Goodman comes to us from theMemorial Sloan-Kettering Cancer Center where she had been a faculty member for eight years. Dr. Goodman obtained her undergraduate and medical degrees from Stanford University and spent a year as a Research Fellow at the Division of Reproductive Health of Centers for Disease Control in Atlanta. She then completed a residency in Radiation Oncology at Memorial Sloan-Kettering followed by some time on the faculty at Stanford before returning to New York. 


Dr. Goodman is an internationally recognized expert in Gastrointestinal Cancer and has served in numerous leadership roles in a variety of ASTRO, ASCO, and RTOG/NRG committees. In addition to clinical activities in the area of GI cancer, she will be assuming the role of Medical Director of the Clinical Trials Office of the University of Colorado Cancer Center and will also serve as Assistant Director of the UC Health Oncology Services line.

Dr. Goodman is joined in Denver by her husband, Dr. Florian Aalami, President and CEO of ADAPT, a company specializing in structural engineering software, and their children, Arianna and Sophia.

7/31/15 - Six members elected to ASTRO’s Board of Directors and Nominating Committee​
The American Society for Radiation Oncology’s (ASTRO’s) members have elected three new officers to the Board of Directors and three members to serve on the Nominating Committee. Terms for all positions begin at the Annual Business Meeting on Tuesday, October 20, 2015 at 11:30 a.m. Central time, at ASTRO’s 57th Annual Meeting at the Henry B. González Convention Center in San Antonio.

The new officers to the Board of Directors are:

Brian D. Kavanagh, MD, MPH, FASTRO, University of Colorado School of Medicine, Denver

Dr. Kavanagh is professor and interim chair of the Department of Radiation Oncology at the University of Colorado School of Medicine, Denver, and an attending physician at the University of Colorado Hospital. Kavanagh is an active clinician with a primary focus on stereotactic body radiation therapy (SBRT) and population data-based health services research. He is Co-Director of the ASTRO-AANS Stereotactic Radiosurgery (SRS) Registry, and he has served ASTRO as a member of the Board of Directors (2011 to 2015) as the Vice-chair and then the Chair of the Health Policy Council; as Chair of the Payment Reform Task Group; and as a member of the Health Policy Council Regulatory Committee, the Communications Committee, the Clinical Affairs and Quality Committee, and the Code Development and Valuation Committee. His additional service has included the Center for Medicare and Medicaid Services’ Hospital Outpatient Payment Advisory Panel and the Ambulatory Payment Classification (APC) Advisory Panel, as well as a member of the National Comprehensive Cancer Network’s (NCCN) Policy Advisory Group. Continue Reading...​

7/13/15 - Lucido off to Mayo Clinic; Physics Residency wins CAMPEP re-accreditation

lucido.jpgJohn Lucido, PhD, our most recent graduate of the Medical Physics Residency Program, has accepted an offer to join the Mayo Clinic Department of Radiation Oncology in Rochester, Minnesota. John joined our program in 2013 after receiving his Ph.D. in medical physics from the University of British Columbia.  "John earned high praise for his performance during his training period with us, and we are all thrilled that he will be joining an outstanding group at Mayo", says Dr. Leah Schubert, Assistant Professor of Radiation Oncology and Co-Director of the Medical Physics Residency Program.

Other exciting news from our medical physics group is that the residency program has received continuation of accreditation from the Commission on Accreditation of Medical Physics Education Programs (CAMPEP) through the end of 2017.  The program started in 2012 and is the first accredited medical physics residency program in the Rocky Mountain region.  Adds Dr. Moyed Miften, Professor and Chief of the Medical Physics section, "The program has been very successful and in 2015 it received 182 applications for one residency position."


6/30/15- Follweiler wins First Annual Schuchman Professionalism Award
FullSizeRender.jpgChristina (Tina) Follweiler, B.S. R. T. (R) (T), was recently presented with the inaugural Annual Terri Schuchman Professionalism Award in the University of Colorado Hospital Department of Radiation Oncology. The award honors Terri Schuchman, who retired last year after an exemplary career at UCH, during which time she consistently exemplified a compassionate approach to patient care alongside attention to detail and an impeccable work ethic and sense of responsibility. The award was chosen by members of the Radiation Oncology Department Based Council and was presented to Tina on June 11, 2015, at the annual department awards and graduation ceremony, by David Westerly, Chair of the DBC. Terri was also on hand to assist with the presentation.
3/20/15- Fisher and Koo receive funding to study new therapy in metastatic breast cancer patient

Description: KooDr. Christine M. Fisher, Assistant Professor of Radiation Oncology and Residency Program Director, and Dr. Philip Koo, Section Chief for Nuclear Medicine and Molecular Imaging, were recently awarded a $500,000 grant from Bayer to support a research study investigating a novel treatment for breast cancer patients with disease that has metastasized to bone. 

The major focus of the project will be to refine treatment methods for metastatic breast cancer patients that may have a higher burden of bony disease. These tumors can act very aggressively and grow to invade surrounding normal structures in the spine, causing neurological dysfunction, pain, fractures, and other problems. In such cases, it is necessary to use local therapy such as high doses of radiation or orthopedic surgery as possible in an effort to stop debilitating local progression of the disease. However, it is difficult to treat many sites at once while protecting the bone marrow, which is a potential major advantage of Radium 223 being studied. 

In this trial, the goal will be to treat the bony disease while maintaining high quality of life for our metastatic breast cancer patients.  Outcomes studied will include not only time until new bony events, but also patient-centered metrics such as pain and need for narcotic pain medicine.  This will offer another tool in the armamentarium of treatment options for our patients at the University of Colorado Diane O’Connor Thompson Breast Center.  

2/2/2015 Moyed Miften and Bernard Jones: Awarded research funding for treating pancreas cancer: 
 Moyed Miften, PhD, Professor and Chief of Medical Physics (left), and Bernard Jones, PhD, Assistant Professor (right), recently were awarded a $194,000 contract from Varian Medical Systems. The money will support their research project entitled, “Patient-Specific Tumor Motion and Respiratory Gated Radiation Delivery for Pancreatic SBRT.”  It is to study new, aggressive techniques for pancreatic cancer radiotherapy. Continue reading...​